AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.
InMode’s Q2 2024 revenue dropped by 36.5% YoY to $86.4M, underlining macroeconomic challenges. Read why I upgrade INMD stock ...
Travis Scott has released so many sneakers with Nike and Jordan Brand that it can be hard to believe the collaborations only ...
Just because "everyone" did something in the past doesn't mean it was okay then. And it definitely doesn't mean it's ...
The automotive plastic market in BRIC countries is set to grow from USD 75.2B in 2024 to USD 146.5B by 2034, with a 6.9% CAGR.